BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 13 filers reported holding BIOMX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 1 | -50.0% | 0.00% | – |
| Q4 2022 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 2 | +100.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q3 2021 | $36,000 | -39.0% | 11,863 | +40.3% | 0.00% | – |
| Q1 2020 | $59,000 | – | 8,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,133,402 | $3,413,000 | 0.39% |
| MMCAP International Inc. SPC | 684,451 | $1,095,000 | 0.07% |
| Kepos Capital LP | 450,597 | $721,000 | 0.06% |
| Orbimed Advisors | 2,813,489 | $4,502,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 98,700 | $158,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 106,696 | $171,000 | 0.00% |
| J. Goldman & Co LP | 150,000 | $15,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31,106 | $50,000 | 0.00% |
| Renaissance Technologies | 76,300 | $122,000 | 0.00% |
| UBS Group AG | 7,217 | $12,000 | 0.00% |